Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.

Engdahl E, Gustafsson R, Huang J, Biström M, Lima Bomfim I, Stridh P, Khademi M, Brenner N, Butt J, Michel A, Jons D, Hortlund M, Alonso-Magdalena L, Hedström AK, Flamand L, Ihira M, Yoshikawa T, Andersen O, Hillert J, Alfredsson L, Waterboer T, Sundström P, Olsson T, Kockum I, Fogdell-Hahn A.

Front Immunol. 2019 Nov 26;10:2715. doi: 10.3389/fimmu.2019.02715. eCollection 2019.

2.

Leptin levels are associated with multiple sclerosis risk.

Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P.

Mult Scler. 2020 Feb 7:1352458520905033. doi: 10.1177/1352458520905033. [Epub ahead of print]

PMID:
32028836
3.

Prevention of post-dural puncture headache - a randomized controlled trial.

Salzer J, Granåsen G, Sundström P, Vågberg M, Svenningsson A.

Eur J Neurol. 2020 Jan 29. doi: 10.1111/ene.14158. [Epub ahead of print]

PMID:
31997481
4.

High serum concentration of vitamin D may protect against multiple sclerosis.

Biström M, Alonso-Magdalena L, Andersen O, Jons D, Gunnarsson M, Vrethem M, Hultdin J, Sundström P.

Mult Scler J Exp Transl Clin. 2019 Dec 6;5(4):2055217319892291. doi: 10.1177/2055217319892291. eCollection 2019 Oct-Dec.

5.

Isolation and Characterization of MAIT Cells from Tumor Tissues.

Rodin W, Sundström P, Quiding Järbrink M.

Methods Mol Biol. 2020;2098:39-53. doi: 10.1007/978-1-0716-0207-2_3.

PMID:
31792814
6.

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Granqvist M, Burman J, Gunnarsson M, Lycke J, Nilsson P, Olsson T, Sundström P, Svenningsson A, Vrethem M, Frisell T, Piehl F.

Mult Scler. 2019 Aug 8:1352458519866600. doi: 10.1177/1352458519866600. [Epub ahead of print]

PMID:
31392923
7.

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Tengvall K, Huang J, Hellström C, Kammer P, Biström M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundström P, Nilsson P, Waterboer T, Olsson T, Kockum I.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16955-16960. doi: 10.1073/pnas.1902623116. Epub 2019 Aug 2.

8.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
9.

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules.

Sundström P, Szeponik L, Ahlmanner F, Sundquist M, Wong JSB, Lindskog EB, Gustafsson B, Quiding-Järbrink M.

Oncotarget. 2019 Apr 19;10(29):2810-2823. doi: 10.18632/oncotarget.26866. eCollection 2019 Apr 19.

10.

Inflammatory activity and vitamin D levels in an MS population treated with rituximab.

Linden J, Granåsen G, Salzer J, Svenningsson A, Sundström P.

Mult Scler J Exp Transl Clin. 2019 Feb 11;5(1):2055217319826598. doi: 10.1177/2055217319826598. eCollection 2019 Jan-Mar.

11.

Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.

de Flon P, Laurell K, Sundström P, Blennow K, Söderström L, Zetterberg H, Gunnarsson M, Svenningsson A.

Acta Neurol Scand. 2019 May;139(5):462-468. doi: 10.1111/ane.13078. Epub 2019 Mar 5.

PMID:
30740668
12.

CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function.

Ahlmanner F, Sundström P, Akeus P, Eklöf J, Börjesson L, Gustavsson B, Lindskog EB, Raghavan S, Quiding-Järbrink M.

Oncotarget. 2018 Dec 11;9(97):36993-37007. doi: 10.18632/oncotarget.26435. eCollection 2018 Dec 11.

13.

Viremia preceding multiple sclerosis: Two nested case-control studies.

Hultin E, Mühr LSA, Bzhalava Z, Hortlund M, Lagheden C, Sundström P, Dillner J.

Virology. 2018 Jul;520:21-29. doi: 10.1016/j.virol.2018.04.006. Epub 2018 May 14.

14.

Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APCmin/+ mice.

Akeus P, Szeponik L, Ahlmanner F, Sundström P, Alsén S, Gustavsson B, Sparwasser T, Raghavan S, Quiding-Järbrink M.

Cancer Immunol Immunother. 2018 Jul;67(7):1067-1077. doi: 10.1007/s00262-018-2161-9. Epub 2018 Apr 18.

15.

Release of transcriptional repression through the HCR promoter region confers uniform expression of HWP1 on surfaces of Candida albicans germ tubes.

Kim S, Nguyen QB, Wolyniak MJ, Frechette G, Lehman CR, Fox BK, Sundstrom P.

PLoS One. 2018 Feb 13;13(2):e0192260. doi: 10.1371/journal.pone.0192260. eCollection 2018.

16.

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.

de Flon P, Söderström L, Laurell K, Dring A, Sundström P, Gunnarsson M, Svenningsson A.

PLoS One. 2018 Feb 8;13(2):e0192516. doi: 10.1371/journal.pone.0192516. eCollection 2018.

17.

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

Novakova L, Zetterberg H, Sundström P, Axelsson M, Khademi M, Gunnarsson M, Malmeström C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J.

Neurology. 2017 Nov 28;89(22):2230-2237. doi: 10.1212/WNL.0000000000004683. Epub 2017 Oct 27.

18.

Managing Epstein-Barr virus and other risk factors in MS-Future perspectives.

Sundström P.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:31-33. doi: 10.1111/ane.12841. Review.

PMID:
29068493
19.

How to minimize the risk for headache? A lumbar puncture practice questionnaire study.

Salzer J, Rajda C, Sundström P, Vågberg M, Vécsei L, Svenningsson A.

Ideggyogy Sz. 2016 Nov 30;69(11-12):397-402. doi: 10.18071/isz.69.0397.

PMID:
29733557
20.

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.

Salzer J, Svenningsson R, Alping P, Novakova L, Björck A, Fink K, Islam-Jakobsson P, Malmeström C, Axelsson M, Vågberg M, Sundström P, Lycke J, Piehl F, Svenningsson A.

Neurology. 2016 Nov 15;87(20):2074-2081. Epub 2016 Oct 19.

21.

The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.

Wickström A, Fagerström M, Wickström L, Granåsen G, Dahle C, Vrethem M, Sundström P.

Mult Scler. 2017 Jul;23(8):1137-1147. doi: 10.1177/1352458516671818. Epub 2016 Oct 6.

PMID:
27758955
22.

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T.

Mult Scler. 2017 Mar;23(3):395-402. doi: 10.1177/1352458516654310. Epub 2016 Jul 11.

PMID:
27325604
23.

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.

de Flon P, Gunnarsson M, Laurell K, Söderström L, Birgander R, Lindqvist T, Krauss W, Dring A, Bergman J, Sundström P, Svenningsson A.

Neurology. 2016 Jul 12;87(2):141-7. doi: 10.1212/WNL.0000000000002832. Epub 2016 Jun 17.

PMID:
27316241
24.

Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism.

Sundström P, Stenstad H, Langenes V, Ahlmanner F, Theander L, Ndah TG, Fredin K, Börjesson L, Gustavsson B, Bastid J, Quiding-Järbrink M.

Cancer Immunol Res. 2016 Mar;4(3):183-93. doi: 10.1158/2326-6066.CIR-15-0050. Epub 2016 Jan 19.

25.

Vitamin D and axonal injury in multiple sclerosis.

Sandberg L, Biström M, Salzer J, Vågberg M, Svenningsson A, Sundström P.

Mult Scler. 2016 Jul;22(8):1027-31. doi: 10.1177/1352458515606986. Epub 2015 Oct 13.

PMID:
26462862
26.

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.

Wickström A, Sundström P, Wickström L, Dahle C, Vrethem M, Svenningsson A.

Mult Scler J Exp Transl Clin. 2015 Sep 22;1:2055217315608203. doi: 10.1177/2055217315608203. eCollection 2015 Jan-Dec.

27.

Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ.

Sundström P, Ahlmanner F, Akéus P, Sundquist M, Alsén S, Yrlid U, Börjesson L, Sjöling Å, Gustavsson B, Wong SB, Quiding-Järbrink M.

J Immunol. 2015 Oct 1;195(7):3472-81. doi: 10.4049/jimmunol.1500258. Epub 2015 Aug 21.

28.

Vitamin D and multiple sclerosis—from epidemiology to prevention.

Sundström P, Salzer J.

Acta Neurol Scand. 2015;132(199):56-61. doi: 10.1111/ane.12432. Review.

PMID:
26046560
29.

Increasing prevalence of multiple sclerosis in Västerbotten County of Sweden.

Svenningsson A, Salzer J, Vågberg M, Sundström P, Svenningsson A.

Acta Neurol Scand. 2015 Dec;132(6):389-94. doi: 10.1111/ane.12408. Epub 2015 Apr 10.

PMID:
25857351
30.

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Svenningsson A, Sundstrom P, Salzer J, Vagberg M.

Neurology. 2014 Nov 25;83(22):2099-100. doi: 10.1212/01.wnl.0000457455.74798.9a. No abstract available. Erratum in: Neurology. 2015 Feb 24;84(8):862.

PMID:
25422402
31.

Lumbar puncture preferences among Swedish neurologists.

Salzer J, Sundström P, Vågberg M, Svenningsson A.

Neurol Res. 2015 Jan;37(1):92-4. doi: 10.1179/1743132814Y.0000000442. Epub 2014 Sep 12.

PMID:
25213597
32.

Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.

Jons D, Sundström P, Andersen O.

Acta Neurol Scand. 2015 Feb;131(2):69-79. doi: 10.1111/ane.12294. Epub 2014 Sep 11. Review.

PMID:
25208981
33.

Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells.

Lingblom C, Bergquist H, Johnsson M, Sundström P, Quiding-Järbrink M, Bove M, Wennerås C.

Inflammation. 2014 Dec;37(6):1932-44. doi: 10.1007/s10753-014-9926-x.

PMID:
24870064
34.

[The law does not prevent health care professionals from reading patient data].

Sundström P, Jacobsson M.

Lakartidningen. 2013 Dec 4-17;110(49-50):2216-7. Swedish. No abstract available.

PMID:
24494392
35.

Vitamin D and multiple sclerosis: where do we go from here?

Salzer J, Biström M, Sundström P.

Expert Rev Neurother. 2014 Jan;14(1):9-18. doi: 10.1586/14737175.2014.864952. Epub 2013 Dec 9. Review.

PMID:
24320602
36.

The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age.

Salzer J, Stenlund H, Sundström P.

Mult Scler. 2014 May;20(6):747-50. doi: 10.1177/1352458513507820. Epub 2013 Oct 9.

PMID:
24107308
37.

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.

Sundqvist E, Bergström T, Daialhosein H, Nyström M, Sundström P, Hillert J, Alfredsson L, Kockum I, Olsson T.

Mult Scler. 2014 Feb;20(2):165-73. doi: 10.1177/1352458513494489. Epub 2013 Sep 2.

PMID:
23999606
38.

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.

Axelsson M, Malmeström C, Gunnarsson M, Zetterberg H, Sundström P, Lycke J, Svenningsson A.

Mult Scler. 2014 Jan;20(1):43-50. doi: 10.1177/1352458513490544. Epub 2013 May 23.

PMID:
23702432
39.

Timing of cigarette smoking as a risk factor for multiple sclerosis.

Salzer J, Sundström P.

Ther Adv Neurol Disord. 2013 May;6(3):205. doi: 10.1177/1756285613479427. No abstract available.

40.

Impaired migration of IgA-secreting cells to colon adenocarcinomas.

Muthuswamy RV, Sundström P, Börjesson L, Gustavsson B, Quiding-Järbrink M.

Cancer Immunol Immunother. 2013 Jun;62(6):989-97. doi: 10.1007/s00262-013-1410-1. Epub 2013 Apr 17.

PMID:
23591979
41.

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.

Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P.

Mult Scler. 2013 Oct;19(12):1587-91. doi: 10.1177/1352458513483888. Epub 2013 Apr 2.

PMID:
23549431
42.

Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.

Sundström P, Salzer J.

Biomark Med. 2013 Apr;7(2):193-5. doi: 10.2217/bmm.13.10. No abstract available.

PMID:
23547812
43.

Vitamin A and systemic inflammation as protective factors in multiple sclerosis.

Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.

Mult Scler. 2013 Jul;19(8):1046-51. doi: 10.1177/1352458512472752. Epub 2013 Jan 18.

PMID:
23334316
44.

Smoking as a risk factor for multiple sclerosis.

Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.

Mult Scler. 2013 Jul;19(8):1022-7. doi: 10.1177/1352458512470862. Epub 2012 Dec 20.

PMID:
23257617
45.

Vitamin D as a protective factor in multiple sclerosis.

Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.

Neurology. 2012 Nov 20;79(21):2140-5. doi: 10.1212/WNL.0b013e3182752ea8.

PMID:
23170011
46.

Automated determination of brain parenchymal fraction in multiple sclerosis.

Vågberg M, Lindqvist T, Ambarki K, Warntjes JB, Sundström P, Birgander R, Svenningsson A.

AJNR Am J Neuroradiol. 2013 Mar;34(3):498-504. doi: 10.3174/ajnr.A3262. Epub 2012 Sep 13.

47.

Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.

Sundqvist E, Sundström P, Lindén M, Hedström AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T.

Neurology. 2012 Sep 25;79(13):1363-8. Epub 2012 Aug 29.

PMID:
22933744
48.

Human oral keratinocytes: a model system to analyze host-pathogen interactions.

Wöllert T, Rollenhagen C, Langford GM, Sundstrom P.

Methods Mol Biol. 2012;845:289-302. doi: 10.1007/978-1-61779-539-8_19.

PMID:
22328382
49.

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

Sundqvist E, Sundström P, Lindén M, Hedström AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T.

Genes Immun. 2012 Jan;13(1):14-20. doi: 10.1038/gene.2011.42. Epub 2011 Jul 21.

PMID:
21776012
50.

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J.

Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8.

PMID:
21280078

Supplemental Content

Loading ...
Support Center